当前蛋白身份:Q13464 重新检索
本组结构的主要差异维度
构建体不同 突变/修饰不同 组装状态不同 配体/离子不同 实验环境不同 结构质量指标不同

差异标签只比较当前检索结果;所有PDB和assembly原始记录仍分别保留。

相关结构差异明细

一行代表一个 PDB 条目中的一个 biological assembly;同一蛋白的多个单体会分别列出。

PDB 条目 Assembly / 聚集状态 构建体 突变与修饰 配体、离子与非聚合物 实验方法 实验环境 结构质量
1S1C Crystal structure of the complex between the human RhoA and Rho-binding domain of human ROCKI 提交 2004-01-06 Assembly 1 蛋白异源复合物 异源复合物;蛋白 × 4 PDB 声明:tetrameric(4) 与蛋白数一致
链 X 946–1015(70 aa) 片段:Rho-binding domain of ROCKI, residues 947-1015
链 Y 946–1015(70 aa) 片段:Rho-binding domain of ROCKI, residues 947-1015
未记录 MG MAGNESIUM ION × 2 GNP PHOSPHOAMINOPHOSPHONIC ACID-GUANYLATE ESTER × 2 X-RAY DIFFRACTION
X-ray结晶条件 EVAPORATION;pH 7.5;293 K;TRIS, PEG 3350, isopropyl alcohol, pH 7.5, EVAPORATION, temperature 293K
分辨率 2.60 Å R-free 0.257
2ESM Crystal Structure of ROCK 1 bound to fasudil 提交 2005-10-26 Assembly 1 蛋白同源多聚体 同源多聚体;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 A 6–415(410 aa) 片段:N-terminal kinase domain, residue 6-415
链 B 6–415(410 aa) 片段:N-terminal kinase domain, residue 6-415
未记录 M77 5-(1,4-DIAZEPAN-1-SULFONYL)ISOQUINOLINE × 2 X-RAY DIFFRACTION
X-ray结晶条件 pH 5.5;298 K;0.45mM protein, 5% PEG3350, 100mM MES, 50mM CaCl2, 10mM DTT, VAPOR DIFFUSION, HANGING DROP, temperature 298K, pH 5.50
分辨率 3.20 Å R-free 0.269
2ETK Crystal Structure of ROCK 1 bound to hydroxyfasudil 提交 2005-10-27 Assembly 1 蛋白同源多聚体 同源多聚体;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 A 6–415(410 aa) 片段:N-terminal and kinase domain, residues 6-415
链 B 6–415(410 aa) 片段:N-terminal and kinase domain, residues 6-415
未记录 HFS 1-(1-HYDROXY-5-ISOQUINOLINESULFONYL)HOMOPIPERAZINE × 2 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 5.5;298 K;4.5% PEG3350, 100mM Mes, pH 5.5, 50mM CaCl2, 10mM DTT, VAPOR DIFFUSION, HANGING DROP, temperature 298K
分辨率 2.96 Å R-free 0.298
2ETR Crystal Structure of ROCK I bound to Y-27632 提交 2005-10-27 Assembly 1 蛋白同源多聚体 同源多聚体;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 A 6–415(410 aa) 片段:N-terminal and kinase domain, residues 6-415
链 B 6–415(410 aa) 片段:N-terminal and kinase domain, residues 6-415
未记录 Y27 (R)-TRANS-4-(1-AMINOETHYL)-N-(4-PYRIDYL) CYCLOHEXANECARBOXAMIDE × 2 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 5.5;298 K;4.5% PEG3350, 100mM MES, pH 5.5, 50mM CaCl2, 10mM DTT, 0.45 mM protein, VAPOR DIFFUSION, HANGING DROP, temperature 298K
分辨率 2.60 Å R-free 0.266
2V55 Mechanism of multi-site phosphorylation from a ROCK-I:RhoE complex structure 提交 2008-10-01 Assembly 1 蛋白异源复合物 异源复合物;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 A 1–406(406 aa) 片段:KINASE DOMAIN, RESIDUES 1-406
未记录 ANP PHOSPHOAMINOPHOSPHONIC ACID-ADENYLATE ESTER × 1 MG MAGNESIUM ION × 2 GTP GUANOSINE-5'-TRIPHOSPHATE × 1 X-RAY DIFFRACTION
X-ray结晶条件 pH 6.5;0.6 - 1 M NA/K TARTRATE, 0.1 M MES [PH 5-6], 0.2 M LISO4
分辨率 3.71 Å R-free 0.269
2V55 Mechanism of multi-site phosphorylation from a ROCK-I:RhoE complex structure 提交 2008-10-01 Assembly 2 蛋白异源复合物 异源复合物;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 C 1–406(406 aa) 片段:KINASE DOMAIN, RESIDUES 1-406
未记录 ANP PHOSPHOAMINOPHOSPHONIC ACID-ADENYLATE ESTER × 1 MG MAGNESIUM ION × 2 GTP GUANOSINE-5'-TRIPHOSPHATE × 1 SO4 SULFATE ION × 1 X-RAY DIFFRACTION
X-ray结晶条件 pH 6.5;0.6 - 1 M NA/K TARTRATE, 0.1 M MES [PH 5-6], 0.2 M LISO4
分辨率 3.71 Å R-free 0.269
3D9V CRYSTAL STRUCTURE OF ROCK I BOUND TO H-1152P A DI-METHYLATED VARIANT OF FASUDIL 提交 2008-05-27 Assembly 1 蛋白同源多聚体 同源多聚体;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 A 6–415(410 aa) 片段:N-terminal and kinase domain, residues 6-415
链 B 6–415(410 aa) 片段:N-terminal and kinase domain, residues 6-415
未记录 H52 (S)-2-METHYL-1-[(4-METHYL-5-ISOQUINOLINE)SULFONYL]-HOMOPIPERAZINE × 2 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION;pH 5.5;298 K;4.5% PEG3350, 100mM MES, PH 5.5,0.45mM PROTEIN, 50mM CACL2, 10mM DTT, pH 5.50, vapor diffusion, temperature 298K
分辨率 3.30 Å R-free 0.280
3NCZ X-Ray Co-structure of Rho-Associated Protein Kinase (ROCK1) with a potent 2H-isoquinolin-1-one inhibitor 提交 2010-06-06 Assembly 1 蛋白同源多聚体 同源多聚体;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 A 6–415(410 aa) 片段:N-TERMINAL AND KINASE DOMAIN, RESIDUES 6-415
链 B 6–415(410 aa) 片段:N-TERMINAL AND KINASE DOMAIN, RESIDUES 6-415
未记录 3NC cis-4-amino-N-(7-chloro-1-oxo-1,2-dihydroisoquinolin-6-yl)cyclohexanecarboxamide × 2 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 6;298 K;8.5% PEG3350, 0.1M MES, 50 mM CaCl2, pH 6.0, VAPOR DIFFUSION, HANGING DROP, temperature 298K
分辨率 3.00 Å R-free 0.328
3NCZ X-Ray Co-structure of Rho-Associated Protein Kinase (ROCK1) with a potent 2H-isoquinolin-1-one inhibitor 提交 2010-06-06 Assembly 2 蛋白同源多聚体 同源多聚体;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 C 6–415(410 aa) 片段:N-TERMINAL AND KINASE DOMAIN, RESIDUES 6-415
链 D 6–415(410 aa) 片段:N-TERMINAL AND KINASE DOMAIN, RESIDUES 6-415
未记录 3NC cis-4-amino-N-(7-chloro-1-oxo-1,2-dihydroisoquinolin-6-yl)cyclohexanecarboxamide × 2 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 6;298 K;8.5% PEG3350, 0.1M MES, 50 mM CaCl2, pH 6.0, VAPOR DIFFUSION, HANGING DROP, temperature 298K
分辨率 3.00 Å R-free 0.328
3NDM Crystal structure of Rho-Associated Protein Kinase (ROCK1) with a potent isoquinolone derivative 提交 2010-06-07 Assembly 1 蛋白同源多聚体 同源多聚体;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 A 6–415(410 aa) 片段:N-TERMINAL AND KINASE DOMAIN, RESIDUES 6-415
链 B 6–415(410 aa) 片段:N-TERMINAL AND KINASE DOMAIN, RESIDUES 6-415
未记录 3ND (3S,4R)-N-(7-chloro-1-oxo-1,4-dihydroisoquinolin-6-yl)-4-(4-chlorophenyl)pyrrolidine-3-carboxamide × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 6;298 K;8.5% PEG3350, 0.1M MES, 50 mM CaCl2, pH 6.0, vapor diffusion, hanging drop, temperature 298K
分辨率 3.30 Å R-free 0.310
3NDM Crystal structure of Rho-Associated Protein Kinase (ROCK1) with a potent isoquinolone derivative 提交 2010-06-07 Assembly 2 蛋白同源多聚体 同源多聚体;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 C 6–415(410 aa) 片段:N-TERMINAL AND KINASE DOMAIN, RESIDUES 6-415
链 D 6–415(410 aa) 片段:N-TERMINAL AND KINASE DOMAIN, RESIDUES 6-415
未记录 3ND (3S,4R)-N-(7-chloro-1-oxo-1,4-dihydroisoquinolin-6-yl)-4-(4-chlorophenyl)pyrrolidine-3-carboxamide × 2 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 6;298 K;8.5% PEG3350, 0.1M MES, 50 mM CaCl2, pH 6.0, vapor diffusion, hanging drop, temperature 298K
分辨率 3.30 Å R-free 0.310
3O0Z Crystal structure of a coiled-coil domain from human ROCK I 提交 2010-07-20 Assembly 1 蛋白同源多聚体 同源多聚体;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 A 535–700(166 aa) 片段:coiled-coil domain (unp residues 535-700)
链 B 535–700(166 aa) 片段:coiled-coil domain (unp residues 535-700)
非标准单体:是(mmCIF未提供具体位点) 非标准单体:是(mmCIF未提供具体位点) 未记录非水小分子 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 4.9;293 K;13% MPD, 100 mM NaCl, 100 mM sodium acetate, 10 mM DTT, 5% glycerol, 10 mM spermidine, pH 4.9, VAPOR DIFFUSION, HANGING DROP, temperature 293K
分辨率 2.33 Å R-free 0.286
3O0Z Crystal structure of a coiled-coil domain from human ROCK I 提交 2010-07-20 Assembly 2 蛋白同源多聚体 同源多聚体;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 C 535–700(166 aa) 片段:coiled-coil domain (unp residues 535-700)
链 D 535–700(166 aa) 片段:coiled-coil domain (unp residues 535-700)
非标准单体:是(mmCIF未提供具体位点) 非标准单体:是(mmCIF未提供具体位点) 未记录非水小分子 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 4.9;293 K;13% MPD, 100 mM NaCl, 100 mM sodium acetate, 10 mM DTT, 5% glycerol, 10 mM spermidine, pH 4.9, VAPOR DIFFUSION, HANGING DROP, temperature 293K
分辨率 2.33 Å R-free 0.286
3TV7 Human Rho-associated protein kinase 1 (ROCK 1) in COMPLEX WITH RKI1342 提交 2011-09-19 Assembly 1 蛋白同源多聚体 同源多聚体;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 A 6–415(410 aa) 片段:N-terminal kinase domain, residue 6-415
链 B 6–415(410 aa) 片段:N-terminal kinase domain, residue 6-415
未记录 07Q 1-[(1R)-1-(3-methoxyphenyl)ethyl]-3-(4-pyridin-4-yl-1,3-thiazol-2-yl)urea × 2 EDO 1,2-ETHANEDIOL × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;pH 7.4;292 K;10 mg/ml ROCK1, 75 mm hepes pH 7.4, 2.5 % tacsimate ph 7.4, 5 % PEG 5000 MME, VAPOR DIFFUSION, SITTING DROP, temperature 292K
分辨率 2.75 Å R-free 0.253
3TV7 Human Rho-associated protein kinase 1 (ROCK 1) in COMPLEX WITH RKI1342 提交 2011-09-19 Assembly 2 蛋白同源多聚体 同源多聚体;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 C 6–415(410 aa) 片段:N-terminal kinase domain, residue 6-415
链 D 6–415(410 aa) 片段:N-terminal kinase domain, residue 6-415
未记录 07Q 1-[(1R)-1-(3-methoxyphenyl)ethyl]-3-(4-pyridin-4-yl-1,3-thiazol-2-yl)urea × 2 EDO 1,2-ETHANEDIOL × 2 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;pH 7.4;292 K;10 mg/ml ROCK1, 75 mm hepes pH 7.4, 2.5 % tacsimate ph 7.4, 5 % PEG 5000 MME, VAPOR DIFFUSION, SITTING DROP, temperature 292K
分辨率 2.75 Å R-free 0.253
3TWJ Rho-associated protein kinase 1 (ROCK 1) IN COMPLEX WITH RKI1447 提交 2011-09-21 Assembly 1 蛋白同源多聚体 同源多聚体;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 A 6–415(410 aa) 片段:N-terminal kinase domain, residue 6-415
链 B 6–415(410 aa) 片段:N-terminal kinase domain, residue 6-415
未记录 07R 1-[(3-hydroxyphenyl)methyl]-3-(4-pyridin-4-yl-1,3-thiazol-2-yl)urea × 1 EDO 1,2-ETHANEDIOL × 2 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;pH 7.4;291 K;10 MG/ML ROCK1, 75 MM hepes ph 7.4, 2.5 % tacsimate pH 7.4, 5 % PEG 5000 MME, VAPOR DIFFUSION, SITTING DROP, temperature 291K
分辨率 2.90 Å R-free 0.289
3TWJ Rho-associated protein kinase 1 (ROCK 1) IN COMPLEX WITH RKI1447 提交 2011-09-21 Assembly 2 蛋白同源多聚体 同源多聚体;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 C 6–415(410 aa) 片段:N-terminal kinase domain, residue 6-415
链 D 6–415(410 aa) 片段:N-terminal kinase domain, residue 6-415
未记录 07R 1-[(3-hydroxyphenyl)methyl]-3-(4-pyridin-4-yl-1,3-thiazol-2-yl)urea × 1 EDO 1,2-ETHANEDIOL × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;pH 7.4;291 K;10 MG/ML ROCK1, 75 MM hepes ph 7.4, 2.5 % tacsimate pH 7.4, 5 % PEG 5000 MME, VAPOR DIFFUSION, SITTING DROP, temperature 291K
分辨率 2.90 Å R-free 0.289
3V8S Human RHO-ASSOCIATED PROTEIN KINASE 1 (ROCK 1) IN COMPLEX WITH INDAZOLE DERIVATIVE (COMPOUND 18) 提交 2011-12-23 Assembly 1 蛋白同源多聚体 同源多聚体;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 A 6–415(410 aa) 片段:RESIDUE 6-415
链 B 6–415(410 aa) 片段:RESIDUE 6-415
未记录 0HD 1-(1H-indazol-5-yl)-3-(2-phenylethyl)urea × 2 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 7.4;291 K;10 MG/ML ROCK1, 25 MM HEPES PH 7.4, 50 MM MES PH 6.5, 2.5% TACSIMATE PH 7.0, 5% PEG 5000 MME, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 291K
分辨率 2.29 Å R-free 0.236
3V8S Human RHO-ASSOCIATED PROTEIN KINASE 1 (ROCK 1) IN COMPLEX WITH INDAZOLE DERIVATIVE (COMPOUND 18) 提交 2011-12-23 Assembly 2 蛋白同源多聚体 同源多聚体;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 C 6–415(410 aa) 片段:RESIDUE 6-415
链 D 6–415(410 aa) 片段:RESIDUE 6-415
未记录 0HD 1-(1H-indazol-5-yl)-3-(2-phenylethyl)urea × 2 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 7.4;291 K;10 MG/ML ROCK1, 25 MM HEPES PH 7.4, 50 MM MES PH 6.5, 2.5% TACSIMATE PH 7.0, 5% PEG 5000 MME, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 291K
分辨率 2.29 Å R-free 0.236
4L2W Crystal structure of the Shroom-Binding domain of human Rock1 提交 2013-06-04 Assembly 1 蛋白同源多聚体 同源多聚体;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 C 834–914(81 aa) 片段:Shroom binding Domain (UNP residues 834-914)
链 D 834–914(81 aa) 片段:Shroom binding Domain (UNP residues 834-914)
突变:E884A, K885A, E886A 突变:E884A, K885A, E886A 未记录非水小分子 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION;pH 6;277 K;0.1M Citrate, 1.0M Ammonium Sulfate, pH 6.0, VAPOR DIFFUSION, temperature 277K
分辨率 2.49 Å R-free 0.276
4L2W Crystal structure of the Shroom-Binding domain of human Rock1 提交 2013-06-04 Assembly 2 蛋白同源多聚体 同源多聚体;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 A 834–914(81 aa) 片段:Shroom binding Domain (UNP residues 834-914)
链 B 834–914(81 aa) 片段:Shroom binding Domain (UNP residues 834-914)
突变:E884A, K885A, E886A 突变:E884A, K885A, E886A 未记录非水小分子 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION;pH 6;277 K;0.1M Citrate, 1.0M Ammonium Sulfate, pH 6.0, VAPOR DIFFUSION, temperature 277K
分辨率 2.49 Å R-free 0.276
4W7P Crystal Structure of ROCK 1 bound to YB-15-QD37 提交 2014-08-22 Assembly 1 蛋白同源多聚体 同源多聚体;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 A 2–410(409 aa)
链 B 2–410(409 aa)
未记录 3J7 N~1~-[2-(1H-indazol-5-yl)pyrido[3,4-d]pyrimidin-4-yl]-2-methylpropane-1,2-diamine × 2 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;293 K;0.1 M MES PH 5.5, 50 mM CACL2, 7% PEG 3350
分辨率 2.80 Å R-free 0.246
4W7P Crystal Structure of ROCK 1 bound to YB-15-QD37 提交 2014-08-22 Assembly 2 蛋白同源多聚体 同源多聚体;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 C 2–410(409 aa)
链 D 2–410(409 aa)
未记录 3J7 N~1~-[2-(1H-indazol-5-yl)pyrido[3,4-d]pyrimidin-4-yl]-2-methylpropane-1,2-diamine × 2 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;293 K;0.1 M MES PH 5.5, 50 mM CACL2, 7% PEG 3350
分辨率 2.80 Å R-free 0.246
4W7P Crystal Structure of ROCK 1 bound to YB-15-QD37 提交 2014-08-22 Assembly 3 蛋白同源多聚体 同源多聚体;蛋白 × 4 PDB 声明:tetrameric(4) 与蛋白数一致
链 A 2–410(409 aa)
链 B 2–410(409 aa)
链 C 2–410(409 aa)
链 D 2–410(409 aa)
未记录 3J7 N~1~-[2-(1H-indazol-5-yl)pyrido[3,4-d]pyrimidin-4-yl]-2-methylpropane-1,2-diamine × 4 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;293 K;0.1 M MES PH 5.5, 50 mM CACL2, 7% PEG 3350
分辨率 2.80 Å R-free 0.246
4YVC ROCK 1 bound to thiazole inhibitor 提交 2015-03-19 Assembly 1 蛋白同源多聚体 同源多聚体;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 A 6–415(410 aa) 片段:N-terminal kinase domain (UNP residues 6-415)
链 B 6–415(410 aa) 片段:N-terminal kinase domain (UNP residues 6-415)
未记录 4KH 2-fluoro-N-[4-(pyridin-4-yl)-1,3-thiazol-2-yl]benzamide × 2 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 5.5;298 K;0.45 mM protein, 5% PEG3350, 100 mM MES, 50 mM calcium chloride, 10 mM DTT
分辨率 3.20 Å R-free 0.221
4YVE ROCK 1 bound to methoxyphenyl thiazole inhibitor 提交 2015-03-19 Assembly 1 蛋白同源多聚体 同源多聚体;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 A 6–415(410 aa) 片段:N-terminal kinase domain (UNP residues 6-415)
链 B 6–415(410 aa) 片段:N-terminal kinase domain (UNP residues 6-415)
未记录 4KK 2-(3-methoxyphenyl)-N-[4-(pyridin-4-yl)-1,3-thiazol-2-yl]acetamide × 2 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 5.5;298 K;0.45 mM protein, 5% PEG3350, 100 mM MES, 50 mM calcium chloride, 10 mM DTT
分辨率 3.40 Å R-free 0.244
5BML ROCK 1 bound to a pyridine thiazole inhibitor 提交 2015-05-22 Assembly 1 蛋白同源多聚体 同源多聚体;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 A 6–415(410 aa)
链 B 6–415(410 aa)
未记录 4TW N-[4-(2-fluoropyridin-4-yl)thiophen-2-yl]-2-{3-[(methylsulfonyl)amino]phenyl}acetamide × 2 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 5.5;298 K;4.5% PEG3350, 100mM MES, pH 5.5, 50mM CaCl2, 10mM DTT, 0.45 mM protein, VAPOR DIFFUSION, HANGING DROP, temperature 298K
分辨率 2.95 Å R-free 0.235
5F5P Molecular Basis for Shroom2 Recognition by Rock1 提交 2015-12-04 Assembly 1 蛋白异源复合物 异源复合物;蛋白 × 4 PDB 声明:tetrameric(4) 与蛋白数一致
链 C 834–913(80 aa)
链 D 834–913(80 aa)
未记录 CL CHLORIDE ION × 2 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;pH 8.5;293 K;20% PEG 3350, 200 mM Magnesium Chloride, 100 mM Tris pH 8.5
分辨率 3.57 Å R-free 0.287
5F5P Molecular Basis for Shroom2 Recognition by Rock1 提交 2015-12-04 Assembly 2 蛋白异源复合物 异源复合物;蛋白 × 4 PDB 声明:tetrameric(4) 与蛋白数一致
链 E 834–913(80 aa)
链 F 834–913(80 aa)
未记录 未记录非水小分子 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;pH 8.5;293 K;20% PEG 3350, 200 mM Magnesium Chloride, 100 mM Tris pH 8.5
分辨率 3.57 Å R-free 0.287
5HVU Rho-associated protein kinase 1 (ROCK 1) in complex with a pyridine thiazole piperidine inhibitor 提交 2016-01-28 Assembly 1 蛋白同源多聚体 同源多聚体;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 A 6–415(410 aa)
链 B 6–415(410 aa)
未记录 65R 2-{3-[3-(piperidin-4-yl)propoxy]phenyl}-N-[4-(pyridin-4-yl)-1,3-thiazol-2-yl]acetamide × 2 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 5.5;298 K;4.5% PEG3350, 100mM MES, pH 5.5, 50mM CaCl2, 10mM DTT, 0.45 mM protein, VAPOR DIFFUSION, HANGING DROP, temperature 298K
分辨率 2.80 Å R-free 0.248
5KKS ROCK 1 bound to azaindole thiazole inhibitor 提交 2016-06-22 Assembly 1 蛋白同源多聚体 同源多聚体;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 A 6–415(410 aa)
链 B 6–415(410 aa)
未记录 6U1 2-[3-(methylsulfonylamino)phenyl]-~{N}-[4-(1~{H}-pyrrolo[2,3-b]pyridin-3-yl)-1,3-thiazol-2-yl]ethanamide × 2 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 5.5;298 K;0.45 mM protein, 5% PEG3350, 100 mM MES, 50 mM calcium chloride, 10 mM DTT
分辨率 3.30 Å R-free 0.254
5KKT ROCK 1 bound to azaindole thiazole piperazine inhibitor 提交 2016-06-22 Assembly 1 蛋白同源多聚体 同源多聚体;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 A 6–415(410 aa)
链 B 6–415(410 aa)
未记录 6U2 2-[3-[3-(4-methylpiperazin-1-yl)propoxy]phenyl]-~{N}-[4-(1~{H}-pyrrolo[2,3-b]pyridin-3-yl)-1,3-thiazol-2-yl]ethanamide × 2 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 5.5;298 K;0.45 mM protein, 5% PEG3350, 100 mM MES, 50 mM calcium chloride, 10 mM DTT
分辨率 2.80 Å R-free 0.237
5UZJ Crystal Structure of ROCK1 bound to an aminopyridine inhibitor 提交 2017-02-26 Assembly 1 蛋白同源多聚体 同源多聚体;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 A 6–415(410 aa) 片段:kinase domain
链 B 6–415(410 aa) 片段:kinase domain
未记录 8UV N-[4-(2-aminopyridin-4-yl)-1,3-thiazol-2-yl]-2-(3-methoxyphenyl)acetamide × 2 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION;pH 5.5;298 K;4.5% PEG3350, 100MM MES, 50MM CACL2, 10MM DTT, 0.45 MM PROTEIN, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 298K
分辨率 3.30 Å R-free 0.241
5WNE X-RAY CO-STRUCTURE OF RHO-ASSOCIATED PROTEIN KINASE (ROCK1) WITH A HIGHLY SELECTIVE INHIBITOR 提交 2017-07-31 Assembly 1 蛋白同源多聚体 同源多聚体;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 A 6–415(410 aa) 片段:UNP residues 6-415
链 B 6–415(410 aa) 片段:UNP residues 6-415
未记录 B4J 3,4-dimethoxy-N-({3-[(5-methyl-4,5,6,7-tetrahydro[1,3]thiazolo[5,4-c]pyridin-2-yl)carbamoyl]phenyl}methyl)benzamide × 2 GOL GLYCEROL × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 6;298 K;8.5% PEG3350, 0.1M MES, 50 MM CACL2, PH 6.0
分辨率 2.60 Å R-free 0.246
5WNE X-RAY CO-STRUCTURE OF RHO-ASSOCIATED PROTEIN KINASE (ROCK1) WITH A HIGHLY SELECTIVE INHIBITOR 提交 2017-07-31 Assembly 2 蛋白同源多聚体 同源多聚体;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 C 6–415(410 aa) 片段:UNP residues 6-415
链 D 6–415(410 aa) 片段:UNP residues 6-415
未记录 B4J 3,4-dimethoxy-N-({3-[(5-methyl-4,5,6,7-tetrahydro[1,3]thiazolo[5,4-c]pyridin-2-yl)carbamoyl]phenyl}methyl)benzamide × 2 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 6;298 K;8.5% PEG3350, 0.1M MES, 50 MM CACL2, PH 6.0
分辨率 2.60 Å R-free 0.246
5WNF X-RAY CO-STRUCTURE OF RHO-ASSOCIATED PROTEIN KINASE (ROCK1) WITH A HIGHLY SELECTIVE INHIBITOR 提交 2017-07-31 Assembly 1 蛋白同源多聚体 同源多聚体;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 A 6–415(410 aa) 片段:UNP residues 6-415
链 B 6–415(410 aa) 片段:UNP residues 6-415
未记录 B4V 1-(4-amino-1,2,5-oxadiazol-3-yl)-5-methyl-N-({3-[(5-methyl-4,5,6,7-tetrahydro[1,3]thiazolo[5,4-c]pyridin-2-yl)carbamoyl]phenyl}methyl)-1H-1,2,3-triazole-4-carboxamide × 2 GOL GLYCEROL × 2 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 6;298 K;8.5% PEG3350, 0.1M MES, 50 MM CACL2, PH 6.0
分辨率 2.45 Å R-free 0.247
5WNF X-RAY CO-STRUCTURE OF RHO-ASSOCIATED PROTEIN KINASE (ROCK1) WITH A HIGHLY SELECTIVE INHIBITOR 提交 2017-07-31 Assembly 2 蛋白同源多聚体 同源多聚体;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 C 6–415(410 aa) 片段:UNP residues 6-415
链 D 6–415(410 aa) 片段:UNP residues 6-415
未记录 B4V 1-(4-amino-1,2,5-oxadiazol-3-yl)-5-methyl-N-({3-[(5-methyl-4,5,6,7-tetrahydro[1,3]thiazolo[5,4-c]pyridin-2-yl)carbamoyl]phenyl}methyl)-1H-1,2,3-triazole-4-carboxamide × 2 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 6;298 K;8.5% PEG3350, 0.1M MES, 50 MM CACL2, PH 6.0
分辨率 2.45 Å R-free 0.247
5WNG X-RAY CO-STRUCTURE OF RHO-ASSOCIATED PROTEIN KINASE (ROCK1) WITH A HIGHLY SELECTIVE INHIBITOR 提交 2017-07-31 Assembly 1 蛋白同源多聚体 同源多聚体;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 A 6–415(410 aa) 片段:UNP residues 6-415
链 B 6–415(410 aa) 片段:UNP residues 6-415
未记录 B4Y (2R)-N-(3-cyanophenyl)-2-(3-{[(6S)-6-(dimethylamino)-4,5,6,7-tetrahydro-1,3-benzothiazol-2-yl]carbamoyl}phenyl)pyrrolidine-1-carboxamide × 2 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 6;298 K;8.5% PEG3350, 0.1M MES, 50 MM CACL2, PH 6.0
分辨率 2.90 Å R-free 0.250
5WNG X-RAY CO-STRUCTURE OF RHO-ASSOCIATED PROTEIN KINASE (ROCK1) WITH A HIGHLY SELECTIVE INHIBITOR 提交 2017-07-31 Assembly 2 蛋白同源多聚体 同源多聚体;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 C 6–415(410 aa) 片段:UNP residues 6-415
链 D 6–415(410 aa) 片段:UNP residues 6-415
未记录 B4Y (2R)-N-(3-cyanophenyl)-2-(3-{[(6S)-6-(dimethylamino)-4,5,6,7-tetrahydro-1,3-benzothiazol-2-yl]carbamoyl}phenyl)pyrrolidine-1-carboxamide × 2 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 6;298 K;8.5% PEG3350, 0.1M MES, 50 MM CACL2, PH 6.0
分辨率 2.90 Å R-free 0.250
5WNH X-RAY CO-STRUCTURE OF RHO-ASSOCIATED PROTEIN KINASE (ROCK1) WITH A HIGHLY SELECTIVE INHIBITOR 提交 2017-07-31 Assembly 1 蛋白同源多聚体 同源多聚体;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 A 6–415(410 aa) 片段:UNP residues 6-415
链 B 6–415(410 aa) 片段:UNP residues 6-415
未记录 B5G (2R)-N-(3-cyanophenyl)-2-{3-[(5-methyl-4,5,6,7-tetrahydro[1,3]thiazolo[5,4-c]pyridin-2-yl)carbamoyl]phenyl}pyrrolidine-1-carboxamide × 2 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 6;298 K;8.5% PEG3350, 0.1M MES, 50 MM CACL2, PH 6.0
分辨率 3.10 Å R-free 0.234
5WNH X-RAY CO-STRUCTURE OF RHO-ASSOCIATED PROTEIN KINASE (ROCK1) WITH A HIGHLY SELECTIVE INHIBITOR 提交 2017-07-31 Assembly 2 蛋白同源多聚体 同源多聚体;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 C 6–415(410 aa) 片段:UNP residues 6-415
链 D 6–415(410 aa) 片段:UNP residues 6-415
未记录 B5G (2R)-N-(3-cyanophenyl)-2-{3-[(5-methyl-4,5,6,7-tetrahydro[1,3]thiazolo[5,4-c]pyridin-2-yl)carbamoyl]phenyl}pyrrolidine-1-carboxamide × 2 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 6;298 K;8.5% PEG3350, 0.1M MES, 50 MM CACL2, PH 6.0
分辨率 3.10 Å R-free 0.234
6E9W Crystal structure of Rock1 with a pyridinylbenzamide based inhibitor 提交 2018-08-01 Assembly 1 蛋白同源多聚体 同源多聚体;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 A 6–415(410 aa)
链 B 6–415(410 aa)
未记录 J0P N-[(2,3-dihydro-1,4-benzodioxin-5-yl)methyl]-4-(pyridin-4-yl)benzamide × 2 SO4 SULFATE ION × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;296 K;1-1.5 M lithium sulfate, 0.1 M sodium citrate pH 6.2 to 6.6, 0.5 M ammonium sulfate
分辨率 2.96 Å R-free 0.255
7JOU CRYSTAL STRUCTURE OF RHO-ASSOCIATED PROTEIN KINASE 1 (ROCK1) IN COMPLEX WITH A PHENYLPYRAZOLE AMIDE INHIBITOR 提交 2020-08-07 Assembly 1 蛋白同源多聚体 同源多聚体;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 A 6–415(410 aa)
未记录 VFS N-[(1S)-2-hydroxy-1-phenylethyl]-3-methoxy-4-(1H-pyrazol-4-yl)benzamide × 2 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION;293 K;NULL
分辨率 3.32 Å R-free 0.248
7S25 ROCK1 IN COMPLEX WITH LIGAND G4998 提交 2021-09-03 Assembly 1 蛋白同源多聚体 同源多聚体;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 A 7–402(396 aa) 片段:KINASE DOMAIN
链 B 7–402(396 aa) 片段:KINASE DOMAIN
未记录 CL CHLORIDE ION × 3 86G 2-[3-(methoxymethyl)phenyl]-N-[4-(1H-pyrazol-4-yl)phenyl]acetamide × 2 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 7.5;293 K;15-17% PEG 5K MME, 0.1 M HEPES/NaOH pH 7.5, 5% (v/v) tacsimate pH 7.5
分辨率 2.34 Å R-free 0.271
7S25 ROCK1 IN COMPLEX WITH LIGAND G4998 提交 2021-09-03 Assembly 2 蛋白同源多聚体 同源多聚体;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 C 7–402(396 aa) 片段:KINASE DOMAIN
链 D 7–402(396 aa) 片段:KINASE DOMAIN
未记录 86G 2-[3-(methoxymethyl)phenyl]-N-[4-(1H-pyrazol-4-yl)phenyl]acetamide × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 7.5;293 K;15-17% PEG 5K MME, 0.1 M HEPES/NaOH pH 7.5, 5% (v/v) tacsimate pH 7.5
分辨率 2.34 Å R-free 0.271
7S26 ROCK1 IN COMPLEX WITH LIGAND G5018 提交 2021-09-03 Assembly 1 蛋白同源多聚体 同源多聚体;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 A 6–402(397 aa) 片段:KINASE DOMAIN
链 B 6–402(397 aa) 片段:KINASE DOMAIN
未记录 EPE 4-(2-HYDROXYETHYL)-1-PIPERAZINE ETHANESULFONIC ACID × 2 86K 2-[methyl(phenyl)amino]-1-[4-(1H-pyrrolo[2,3-b]pyridin-3-yl)-3,6-dihydropyridin-1(2H)-yl]ethan-1-one × 2 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 7.5;293 K;15-17% PEG 5K MME, 0.1 M HEPES/NaOH pH 7.5, 5% (v/v) tacsimate pH 7.5
分辨率 2.74 Å R-free 0.269
7S26 ROCK1 IN COMPLEX WITH LIGAND G5018 提交 2021-09-03 Assembly 2 蛋白同源多聚体 同源多聚体;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 C 6–402(397 aa) 片段:KINASE DOMAIN
链 D 6–402(397 aa) 片段:KINASE DOMAIN
未记录 86K 2-[methyl(phenyl)amino]-1-[4-(1H-pyrrolo[2,3-b]pyridin-3-yl)-3,6-dihydropyridin-1(2H)-yl]ethan-1-one × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 7.5;293 K;15-17% PEG 5K MME, 0.1 M HEPES/NaOH pH 7.5, 5% (v/v) tacsimate pH 7.5
分辨率 2.74 Å R-free 0.269
8P0S Crystal structure HR1 domain of Rho-associated coiled-coil protein kinases (ROCK-HR1) 提交 2023-05-10 Assembly 1 蛋白同源多聚体 同源多聚体;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 A 420–550(131 aa)
链 B 420–550(131 aa)
非标准单体:是(mmCIF未提供具体位点) 非标准单体:是(mmCIF未提供具体位点) DTT 2,3-DIHYDROXY-1,4-DITHIOBUTANE × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 7.5;291.15 K;23% PEG 3350, 150 mM Tri-potassium citrate and 4% MPD (2-methyl-2,4-pentanediol)
分辨率 2.20 Å R-free 0.293
8ZH5 The Crystal Structure of the ROCK1 from Biortus. 提交 2024-05-10 Assembly 1 蛋白同源多聚体 同源多聚体;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 A 6–415(410 aa)
未记录 未记录非水小分子 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;293 K;0.1M MgAC2, 0.1M NaAC pH4.5, 8% PEG 8000, 1.0M NDSB-256
分辨率 3.70 Å R-free 0.260